Wal Pranay, Wal Ankita, Bhandari Anil, Pandey Ummeshwar, Rai Awani K
Department of Pharmacy, Jodhpur National University, Jodhpur, Rajasthan, India.
Department of Pharmacy, Pranveer Singh Institute of Technology, Bhauti Road, Kanpur, Uttar Pradesh, India.
J Res Pharm Pract. 2013 Jul;2(3):123-9. doi: 10.4103/2279-042X.122386.
The main objective of this study was to assess the effects of pharmaceutical care interventions in patients with essential hypertension in Lakshmi Pat Singhania Institute of Cardiology, Kanpur, India.
The study was carried out from July 2010 to August 2011. Pharmaceutical care was provided for 54 patients (intervention group) which was comprised of the patient education, the prescription assistance and the life style modifications and motivation for health. Then the clinical outcome as well as health related quality of life (HRQOL) were compared with the control group (48 patients) in which the pharmaceutical care was not provided. Furthermore, the effect of pharmaceutical care intervention on HRQOL was assessed using Short Form-36 (SF-36), a general health related quality of life questionnaire used to evaluate the QOL of patients. Blood pressure (BP) measurements and QOL survey was performed at baseline and at the follow-up session.
The difference between blood pressure readings from the baseline to the second follow-up was significant for systolic [(P = 0.0001), 12.24 mmHg] and diastolic BP [(P = 0.001), 5.17 mmHg] in the intervention group. The questionnaire used to evaluate the QOL of patients also showed improvement in the mean score for intervention group.
Results from our study showed that applying pharmaceutical care to hypertensive patients can help in the control of these patients' blood pressure, and consequently lower the risk that hypertension poses in cardiovascular disease. Successful implementation of pharmaceutical care has the potential to increase patients' satisfaction with their pharmacists' activities and may increase patients' expectations that pharmacists will work on their behalf to assist them with their healthcare needs.
本研究的主要目的是评估在印度坎普尔市拉克希米·帕特·辛格ania心脏病学研究所对原发性高血压患者实施药学服务干预的效果。
本研究于2010年7月至2011年8月进行。为54例患者(干预组)提供药学服务,包括患者教育、处方协助、生活方式改变及健康激励。然后将临床结果以及健康相关生活质量(HRQOL)与未提供药学服务的对照组(48例患者)进行比较。此外,使用简短健康调查问卷(SF - 36)评估药学服务干预对HRQOL的影响,SF - 36是一种用于评估患者生活质量的一般健康相关生活质量问卷。在基线和随访时进行血压(BP)测量及生活质量调查。
干预组从基线到第二次随访时收缩压[(P = 0.0001),12.24 mmHg]和舒张压[(P = 0.001),5.17 mmHg]的血压读数差异显著。用于评估患者生活质量的问卷也显示干预组的平均得分有所改善。
我们的研究结果表明,对高血压患者实施药学服务有助于控制这些患者的血压,从而降低高血压在心血管疾病中所带来的风险。成功实施药学服务有可能提高患者对药剂师工作的满意度,并可能增加患者对药剂师代表他们努力满足其医疗保健需求的期望。